Correlation Between Cellectar Biosciences and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Cellectar Biosciences and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectar Biosciences and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellectar Biosciences and Revelation Biosciences, you can compare the effects of market volatilities on Cellectar Biosciences and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectar Biosciences with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectar Biosciences and Revelation Biosciences.
Diversification Opportunities for Cellectar Biosciences and Revelation Biosciences
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cellectar and Revelation is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Cellectar Biosciences and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Cellectar Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectar Biosciences are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Cellectar Biosciences i.e., Cellectar Biosciences and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Cellectar Biosciences and Revelation Biosciences
Given the investment horizon of 90 days Cellectar Biosciences is expected to under-perform the Revelation Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Cellectar Biosciences is 1.5 times less risky than Revelation Biosciences. The stock trades about -0.1 of its potential returns per unit of risk. The Revelation Biosciences is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 5,440 in Revelation Biosciences on December 2, 2024 and sell it today you would lose (5,091) from holding Revelation Biosciences or give up 93.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cellectar Biosciences vs. Revelation Biosciences
Performance |
| Timeline |
| Cellectar Biosciences |
| Revelation Biosciences |
Cellectar Biosciences and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cellectar Biosciences and Revelation Biosciences
The main advantage of trading using opposite Cellectar Biosciences and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectar Biosciences position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Cellectar Biosciences vs. Monopar Therapeutics | Cellectar Biosciences vs. Pulmatrix | Cellectar Biosciences vs. Tenax Therapeutics | Cellectar Biosciences vs. Bio Path Holdings |
| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |